Management

"SK hynix Considers Selling Stake in Chongqing Plant in China, Among Other Options"

Bloomberg Report: Sale Options Under Discussion Valuation Expected to Reach $3 Billion; Chinese Funds Among Those Mentioned

KIM JUNG YOU
2026-08-09 09:20:28
[Edaily Reporter KIM JUNG YOU ] Foreign media reported that SK hynix(000660)is considering a plan to sell its stake in a semiconductor back-end (packaging) plant in Chongqing, China.

According to a Bloomberg report on the 7th (local time), SK hynix is reportedly discussing various options with advisory firms regarding the sale of its Chongqing packaging plant.

Bloomberg reported that if the sale proceeds, the value of the stake could reach approximately $3 billion (about 4 trillion Hanwha won). The outlet noted that potential buyers for the Chongqing plant include Chinese funds and Chinese semiconductor companies, and that SK hynix may retain a minority stake.

However, Bloomberg reported, citing local sources, that these discussions are still in the early stages and may not materialize. Bloomberg added that SK hynix declined to confirm the report.

Meanwhile, SK hynix’s Chongqing plant, which began mass production in July 2014, is one of the company’s Chinese bases responsible for NAND flash packaging and other operations.

Economy

Corporation

IT·Science

Economy

KBI METAL CO., LTD., Which Has Expanded Its Wire and Cable Business, Posts Record Cumulative Operating Profit… but Slows Down in the Third Quarter

KBI METAL CO., LTD.’s Eumseong Plant Office Building. (Photo courtesy of KBI Group) KBI METAL CO., LTD. posted its highest-ever cumulative operating profit for the first three quarters of this year,…
2026-11-13 22:11:12

Corporation

HITEJINRO Enters the Soju-Beer Mix Cans Market… Remarks by Cho Woong-rae, Chairman of Shenyang Soju

“Please continue to look favorably upon our Shenyang Oak Soju.”This is a handwritten message posted by Cho Woong-rae, Chairman of Seonyang Soju, on his Instagram on the 12th. In his handwritten messag…
2026-11-13 19:38:55

IT·Science

HANDOK Inc.: Partner Company’s Rare Hypoglycemia Treatment Set to Draw Attention This Year… Results of External Collaboration Put to the Test

Resolute announced to the U.S. Securities and Exchange Commission (SEC) on the 14th (local time) that it had completed patient enrollment for the Phase 3 clinical trial of “Ersodetug.” (Source: U.S. S…
2026-11-13 15:42:02